22
Participants
Start Date
May 1, 2021
Primary Completion Date
June 10, 2021
Study Completion Date
June 14, 2021
co-occuring mutation
APC, TP53, PIK3CA, KRAS APC, TP53, PIK3CA, MLH1 APC, TP53, PIK3CA, KRAS, and MLH1 APC, TP53, PIK3CA
Vania Myralda Giamour Marbun, Jakarta
Dr Cipto Mangunkusumo General Hospital
OTHER